Table 3.
Outcomes of the 36 endoscopic submucosal dissections (ESDs) for Barrett’s early neoplasia
| Hospital stay (mean ± SD), days | 2.9 ± 2 |
| Early complications, n (%) | 4 (11.1) |
| Bleeding | 0 (0) |
| Perforation | 3 (8.3) |
| Other (anesthesia-related) | 2 (5.6) |
| Late complications, n (%) | |
| Esophageal stricture | 2 (5.6) |
| 30-Day mortality, n (%) | 0 (0) |
| Size of neoplasia on pathological examination (mean ± SD), mm | 12 ± 15 |
| Histological analysis, n (%) | |
| Low-grade dysplasia | 1 (2.8) |
| High-grade dysplasia | 6 (16.7) |
| Adenocarcinoma | 29 (80.5) |
| Infiltration deptha, n (%) | |
| Mucosa | 23 (79.3) |
| SM1 | 1 (3.4) |
| SM > 1 | 5 (17.2) |
| Other histoprognostic factorsa, n (%) | |
| Well differentiated | 26 (89.7) |
| Moderately differentiated | 2 (6.9) |
| Poorly differentiated | 1 (3.4) |
| Lymphovascular invasion | 3 (10.3) |
| Histological quality of the endoscopic resection, n (%) | |
| R0 resection of carcinoma | 21/29 (72.4) |
| Curative resection of carcinomaa | 19/29 (65.5) |
| Curative resection of high-grade dysplasia | 18/35 (51.4) |
| Curative resection of all neoplasia | 16/36 (44.5) |
a
For the 29 adenocarcinomas.